We are live on ! Find out more
UL

Ulys LLC Portfolio holdings

AUM $25.4M
1-Year Est. Return 201.03%
This Fund
S&P 500
This Quarter Est. Return
+21.77%
1 Year Est. Return
+201.03%
3 Year Est. Return
-31.51%
5 Year Est. Return
-50.88%
10 Year Est. Return
AUM
$34.8M
AUM Growth
+$6.35M
Cap. Flow
-$7
Cap. Flow %
-0%
Top 10 Hldgs %
100%
Holding
2
New
Increased
Reduced
1
Closed

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
LXRX icon
Lexicon Pharmaceuticals
LXRX
+$7

Sector Composition

Rank Sector Weight
1 Healthcare 99.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LXRX icon
1
Lexicon Pharmaceuticals
LXRX
$1.04B
$34.8M 99.98%
4,321,214
-1
-0% -$7
CERE
2
DELISTED
CERES, INC. COMMON STOCK NEW
CERE
$8K 0.02%
3,891

Similar funds

Ulys LLC's Q2 2015 Portfolio in Review

As of Q2 2015, Ulys LLC held 2 positions worth $34.8M, up 22% from $28.4M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2015: portfolio turnover was 0%. Ulys LLC opened no new positions and made no exits, leaving the 2-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 100% a quarter earlier.

  • Ulys LLC's biggest Q2 2015 reduction was Lexicon Pharmaceuticals, cutting an estimated $7.
  • Ulys LLC's ten largest holdings make up 100% of its $34.8M portfolio in Q2 2015.
  • Ulys LLC opened 0 new positions and closed 0 in Q2 2015.
  • Ulys LLC's portfolio value rose 22% quarter-over-quarter to $34.8M.

Based on Ulys LLC's 13F filing for Q2 2015, filed 13 Aug 2015.